The Lancet Digital Health in conversation with

Predicting the added benefit of adjuvant chemotherapy

The Lancet

Prof Anant Madabhushi and Dr Samuel talk about the utility of a radiomic risk score applied to CT scans of patients with early stage non-small cell lung carcinoma.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv